Axsome Therapeutics Inc (AXSM)

12:05 PM

AXSM: RBC Capital Raises Price Target and Maintains Outperform Rating | AXSM Stock News - GuruFocus

12:05 PM

10:45 AM

Axsome Therapeutics (NASDAQ:AXSM) Shares Gap Down After Earnings Miss - MarketBeat

10:45 AM

10:28 AM

AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales - TradingView

10:28 AM

10:07 AM

Axsome anticipates expanded market access for SYMBRAVO and AUVELITY while advancing late-stage pipeline - MSN

10:07 AM

09:30 AM

Biologics Market Surges Toward $680B as FDA Accelerates Approval Pathways - The Globe and Mail

09:30 AM

09:27 AM

Axsome Therapeutics (NASDAQ:AXSM) Posts Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat

09:27 AM

08:24 AM

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q3 2025 Earnings Call Transcript - Insider Monkey

08:24 AM

08:10 AM

RBC Raises Price Target on Axsome Therapeutics to $198 From $189, Keeps Outperform Rating - MarketScreener

08:10 AM

07:16 AM

Axsome Therapeutics (AXSM): Net Margin Stays Negative as Growth Expectations Drive Up Valuation Debate - Yahoo Finance

07:16 AM

07:09 AM

Will Axsome Therapeutics Inc. stock go up soonWeekly Stock Recap & High Accuracy Trade Alerts - newser.com

07:09 AM

05:16 AM

Axsome: Q3 Earnings Snapshot - New Haven Register

05:16 AM

04:51 AM

How Axsome Therapeutics Inc. (19X) stock moves in volatile trading sessionsQuarterly Profit Report & Risk Managed Investment Strategies - newser.com

04:51 AM

04:38 AM

Can machine learning forecast Axsome Therapeutics Inc. recoveryQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com

04:38 AM

02:47 AM

How Axsome Therapeutics Inc. stock compares to industry benchmarksWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com

02:47 AM

01:12 AM

Axsome Therapeutics Inc. stock trend forecast2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com

01:12 AM

12:09 PM

Decoding Axsome Therapeutics Inc (AXSM): A Strategic SWOT Insigh - GuruFocus

12:09 PM

Nov 03, 2025

Axsome Therapeutics Reports Strong Q3 2025 Growth - TipRanks

Nov 03, 2025

Nov 03, 2025

Has Axsome Therapeutics Inc. formed a bullish divergenceTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Q3 2025 slides: Strong revenue growth amid pipeline expansion - Investing.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Nov 03, 2025

Nov 03, 2025

Transcript : Axsome Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Nov 03, 2025

Nov 03, 2025

Earnings call transcript: Axsome Therapeutics Q3 2025 reveals revenue beat, stock dips - Investing.com

Nov 03, 2025

Nov 03, 2025

Is Axsome Therapeutics Inc. forming a reversal pattern2025 Market Outlook & Reliable Breakout Forecasts - newser.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Saw Sales Jump But Losses Remain - Finimize

Nov 03, 2025

Nov 03, 2025

Market reaction to Axsome Therapeutics Inc.’s recent newsWeekly Investment Recap & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Q3 Net Loss Narrows, Revenue Rises - MarketScreener

Nov 03, 2025

Nov 03, 2025

Axsome Q3 2025 Financial Results: Revenue Beats, Loss WidensNews and Statistics - IndexBox

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Reports 63% Revenue Growth in Q3 2025 - TipRanks

Nov 03, 2025

Nov 03, 2025

Earnings Flash (AXSM) Axsome Therapeutics Posts Q3 Net Loss $0.94 a Share, vs. FactSet Est of $0.82 Loss - MarketScreener

Nov 03, 2025

Nov 03, 2025

Earnings Flash (AXSM) Axsome Therapeutics, Inc. Reports Q3 Revenue $171.0M, vs. FactSet Est of $163.0M - MarketScreener

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - The Manila Times

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Inc. stock momentum explainedJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Q3 net product revenue jumps 63% - MarketScreener

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Inc. recovery potential after sell offJuly 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Will Axsome Therapeutics Inc. stock sustain high P E ratios2025 Growth vs Value & Daily Stock Trend Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Axsome Therapeutics Inc. stock volume spike explained2025 Dividend Review & Verified Entry Point Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Historical volatility pattern of Axsome Therapeutics Inc. visualized2025 Key Lessons & Daily Technical Forecast Reports - newser.com

Nov 03, 2025

Nov 03, 2025

How Axsome Therapeutics Inc. (19X) stock reacts to Fed tighteningJuly 2025 Analyst Calls & Free Fast Gain Swing Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How rising interest rates impact Axsome Therapeutics Inc. stock2025 Sector Review & Community Shared Stock Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 PreEarnings & Verified Swing Trading Watchlists - newser.com

Nov 03, 2025

Nov 02, 2025

What Wall Street predicts for Axsome Therapeutics Inc. stock pricePortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Is a relief rally coming for Axsome Therapeutics Inc. holders2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com

Nov 02, 2025

Nov 02, 2025

Is Axsome Therapeutics Inc. stock a buy on dips2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com

Nov 02, 2025